New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
08:38 EDTINSMInsmed says to pursue breakthrough therapy designation for Arikayce in the U.S.
Says seeking the "most expeditious path forward" for Arikayce in the EU. Doctors involved in the trial says saw "encouraging" signs in trial, and the company said it is "encouraged" by the achievement of culture conversion in the Phase 2 trial. Comments from the company's conference call discussing results from its U.S. phase 2 clinical trial for treatment resistant nontuberculous mycobacteria lung infections.
News For INSM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for INSM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use